Sigrid Therapeutics is a developer of new diabetes treatment devices. The company mainly develops new medical devices for chronic diseases such as diabetes to improve the clinical efficacy of patients and improve the level of care. Recently, Sigrid Therapeutics raised 10.6 million crowns (about 10.23 million US dollars). Existing and new investors are involved, including recently appointed chairman Mattias Ankarberg.
This article is transferred from: https://www.itjuzi.com/investevent/13784974
This site is only for collection, and the copyright belongs to the original author.